FIELD: medicine.
SUBSTANCE: the present innovation deals with preventing the development of hypoxia due to introducing ceruloplasmin 1 d before hypoxia. The method enables to exclude the development of allergic reactions.
EFFECT: higher efficiency of hypoxia prevention.
2 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
USE OF HUMAN LACTOFERRIN APO FORM AS ANTIHYPOXANT AND HYPOXIA INDUCIBLE FACTOR-1 ALPHA STABILISER | 2011 |
|
RU2465004C1 |
3-(N,N-DIMETHYLCARBAMOYLHYDROXY)-2-ETHYL-6-METHYLPYRIDINE SUCCINATE SHOWING ANTIHYPOXIC ACTIVITY | 1993 |
|
RU2095350C1 |
2-[2-(DIETHYLAMINO) -ETHYLTHIO]-5,6- DIMETHYLBENZIMIDAZOLE SALTS SHOWING ANTIISCHEMIC, ANTIHYPOXIC AND ANTIARRHYTHMIC ACTIVITY AND 2-[2-(DIETHYLAMINO) -ETHYLTHIO]-5,6- DIMETHYLBENZIMIDAZOLE AS AN INTERMEDIATE PRODUCT FOR SYNTHESIS OF 2-[2-(DIETHYLAMINO) -ETHYLTHIO] -5,6-DIMETHYLBENZIMIDAZOLE SALTS | 1991 |
|
RU2027709C1 |
METHOD OF DETERMINING DEGREE OF RESISTANCE TO HYPOBARIC HYPOXIA IN SMALL LABORATORY ANIMALS | 2014 |
|
RU2563059C1 |
ANTIHYPOXIC AGENT | 1994 |
|
RU2098085C1 |
COLLECTION HAVING ANTIHYPOXIC AND HYPOTENSIVE ACTIONS | 2013 |
|
RU2587722C2 |
ANTIHYPOXIC MEDICINAL AGENT | 2001 |
|
RU2189813C1 |
AGENT SHOWING ANTIHYPOXIC AND ANTIOXIDANT ACTIVITY | 2001 |
|
RU2191592C1 |
DRUG POSSESSING ANTIHYPOXIC, ACTOPROTECTIVE, NOOTROPIC ACTIVITIES AND HAVING EFFECT ON PHYSICAL EFFICIENCY, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2462245C1 |
METHOD OF ADAPTATION OF ANIMAL BODY TO CHRONIC HYPOBARIC HYPOXIA IN EXPERIMENT | 2022 |
|
RU2800891C1 |
Authors
Dates
2005-05-10—Published
2003-02-10—Filed